Titre : Inhibiteur tissulaire de métalloprotéinase-2

Inhibiteur tissulaire de métalloprotéinase-2 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pattern Recognition, Automated
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteur tissulaire de métalloprotéinase-2 : Questions médicales les plus fréquentes", "headline": "Inhibiteur tissulaire de métalloprotéinase-2 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteur tissulaire de métalloprotéinase-2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire de métalloprotéinase-2" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Inhibiteur tissulaire des métalloprotéinases", "url": "https://questionsmedicales.fr/mesh/D019714", "about": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire des métalloprotéinases", "code": { "@type": "MedicalCode", "code": "D019714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.815.875" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire de métalloprotéinase-2", "alternateName": "Tissue Inhibitor of Metalloproteinase-2", "code": { "@type": "MedicalCode", "code": "D019716", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anna Pryczynicz", "url": "https://questionsmedicales.fr/author/Anna%20Pryczynicz", "affiliation": { "@type": "Organization", "name": "Department of Pathomorphology, Medical University of Bialystok, Bialystok, Poland." } }, { "@type": "Person", "name": "Dianchen Wang", "url": "https://questionsmedicales.fr/author/Dianchen%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Hernia and Abdominal Wall Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Road, Zhengzhou, 450052, Henan, China. wdc8681949@163.com." } }, { "@type": "Person", "name": "Yake Chen", "url": "https://questionsmedicales.fr/author/Yake%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Hernia and Abdominal Wall Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Road, Zhengzhou, 450052, Henan, China." } }, { "@type": "Person", "name": "Maryam Raeeszadeh-Sarmazdeh", "url": "https://questionsmedicales.fr/author/Maryam%20Raeeszadeh-Sarmazdeh", "affiliation": { "@type": "Organization", "name": "Chemical and Materials Engineering, University of Nevada, Reno, NV 89557, USA. Electronic address: maryamr@unr.edu." } }, { "@type": "Person", "name": "William G Stetler-Stevenson", "url": "https://questionsmedicales.fr/author/William%20G%20Stetler-Stevenson", "affiliation": { "@type": "Organization", "name": "Extracellular Matrix Pathology Section, Laboratory of Pathology, National Cancer Institute, National Institute of Health, Bethesda, MD, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Channel Selection for Gesture Recognition Using Force Myography: A Universal Model for Gesture Measurement Points.", "datePublished": "2024-05-21", "url": "https://questionsmedicales.fr/article/38771682", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1109/TNSRE.2024.3403941" } }, { "@type": "ScholarlyArticle", "name": "The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.", "datePublished": "2024-05-16", "url": "https://questionsmedicales.fr/article/38754953", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/gutjnl-2023-330995" } }, { "@type": "ScholarlyArticle", "name": "Inhalant abuse among street-involved children and adolescents in India: Case for epistemic recognition and reorientation.", "datePublished": "2024-05-02", "url": "https://questionsmedicales.fr/article/38695149", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jora.12946" } }, { "@type": "ScholarlyArticle", "name": "Adapting multilingual vision language transformers for low-resource Urdu optical character recognition (OCR).", "datePublished": "2024-04-29", "url": "https://questionsmedicales.fr/article/38699211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj-cs.1964" } }, { "@type": "ScholarlyArticle", "name": "A lightweight hybrid model for the automatic recognition of uterine fibroid ultrasound images based on deep learning.", "datePublished": "2024-04-27", "url": "https://questionsmedicales.fr/article/38676550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jcu.23703" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines sécrétoires inhibitrices de protéinases", "item": "https://questionsmedicales.fr/mesh/D053491" }, { "@type": "ListItem", "position": 5, "name": "Inhibiteur tissulaire des métalloprotéinases", "item": "https://questionsmedicales.fr/mesh/D019714" }, { "@type": "ListItem", "position": 6, "name": "Inhibiteur tissulaire de métalloprotéinase-2", "item": "https://questionsmedicales.fr/mesh/D019716" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteur tissulaire de métalloprotéinase-2 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Comment diagnostiquer une anomalie de TIMP-2 ?\nQuels examens sont utilisés pour évaluer TIMP-2 ?\nY a-t-il des biomarqueurs associés à TIMP-2 ?\nQuel rôle joue TIMP-2 dans le diagnostic du cancer ?\nPeut-on mesurer TIMP-2 dans les tissus ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Quels symptômes sont liés à une dysrégulation de TIMP-2 ?\nTIMP-2 est-il associé à des douleurs ?\nY a-t-il des symptômes cutanés liés à TIMP-2 ?\nComment TIMP-2 affecte-t-il la cicatrisation ?\nTIMP-2 influence-t-il les symptômes respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Comment prévenir les déséquilibres de TIMP-2 ?\nY a-t-il des exercices recommandés pour TIMP-2 ?\nLes habitudes alimentaires influencent-elles TIMP-2 ?\nFaut-il éviter certains aliments pour TIMP-2 ?\nLa gestion du stress aide-t-elle TIMP-2 ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Quels traitements ciblent TIMP-2 ?\nPeut-on utiliser des médicaments anti-inflammatoires avec TIMP-2 ?\nY a-t-il des traitements naturels pour TIMP-2 ?\nComment la physiothérapie aide-t-elle avec TIMP-2 ?\nLes traitements ciblant TIMP-2 sont-ils en recherche ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Quelles complications peuvent survenir avec TIMP-2 ?\nTIMP-2 est-il lié à des maladies chroniques ?\nComment TIMP-2 affecte-t-il la santé cardiovasculaire ?\nY a-t-il des risques de cancer liés à TIMP-2 ?\nTIMP-2 peut-il entraîner des complications respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteur tissulaire de métalloprotéinase-2", "description": "Quels facteurs augmentent le risque de déséquilibre de TIMP-2 ?\nLe stress est-il un facteur de risque pour TIMP-2 ?\nY a-t-il des prédispositions génétiques pour TIMP-2 ?\nL'alimentation influence-t-elle le risque de TIMP-2 ?\nLes infections peuvent-elles affecter TIMP-2 ?", "url": "https://questionsmedicales.fr/mesh/D019716?mesh_terms=Pattern+Recognition,+Automated&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie de TIMP-2 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de TIMP-2 peuvent être effectués." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer TIMP-2 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'électrophorèse des protéines et les dosages immunologiques sont courants." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à TIMP-2 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biomarqueurs comme MMPs peuvent être évalués en parallèle." } }, { "@type": "Question", "name": "Quel rôle joue TIMP-2 dans le diagnostic du cancer ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "TIMP-2 peut être un indicateur de la progression tumorale dans certains cancers." } }, { "@type": "Question", "name": "Peut-on mesurer TIMP-2 dans les tissus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent être analysées pour évaluer TIMP-2 localement." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une dysrégulation de TIMP-2 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une inflammation et des troubles de la cicatrisation peuvent survenir." } }, { "@type": "Question", "name": "TIMP-2 est-il associé à des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent être ressenties en raison de l'inflammation tissulaire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés liés à TIMP-2 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des lésions cutanées peuvent apparaître en cas de déséquilibre de TIMP-2." } }, { "@type": "Question", "name": "Comment TIMP-2 affecte-t-il la cicatrisation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction de TIMP-2 peut retarder la cicatrisation des plaies." } }, { "@type": "Question", "name": "TIMP-2 influence-t-il les symptômes respiratoires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une inflammation pulmonaire liée à TIMP-2 peut causer des symptômes respiratoires." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres de TIMP-2 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain et une alimentation équilibrée peuvent aider à prévenir." } }, { "@type": "Question", "name": "Y a-t-il des exercices recommandés pour TIMP-2 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des exercices réguliers peuvent améliorer la santé tissulaire et réguler TIMP-2." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles TIMP-2 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en antioxydants peut moduler TIMP-2." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour TIMP-2 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de limiter les aliments pro-inflammatoires pour TIMP-2." } }, { "@type": "Question", "name": "La gestion du stress aide-t-elle TIMP-2 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress peut réduire l'inflammation et réguler TIMP-2." } }, { "@type": "Question", "name": "Quels traitements ciblent TIMP-2 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs spécifiques sont en développement." } }, { "@type": "Question", "name": "Peut-on utiliser des médicaments anti-inflammatoires avec TIMP-2 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anti-inflammatoires peuvent aider à réguler l'expression de TIMP-2." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour TIMP-2 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent moduler l'activité de TIMP-2." } }, { "@type": "Question", "name": "Comment la physiothérapie aide-t-elle avec TIMP-2 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie peut améliorer la fonction tissulaire affectée par TIMP-2." } }, { "@type": "Question", "name": "Les traitements ciblant TIMP-2 sont-ils en recherche ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études cliniques explorent des traitements innovants pour TIMP-2." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec TIMP-2 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la fibrose tissulaire peuvent se développer." } }, { "@type": "Question", "name": "TIMP-2 est-il lié à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de TIMP-2 sont associés à des maladies chroniques." } }, { "@type": "Question", "name": "Comment TIMP-2 affecte-t-il la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une dysrégulation de TIMP-2 peut contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés à TIMP-2 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de TIMP-2 peuvent être un facteur de risque pour certains cancers." } }, { "@type": "Question", "name": "TIMP-2 peut-il entraîner des complications respiratoires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une inflammation pulmonaire liée à TIMP-2 peut causer des complications respiratoires." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de déséquilibre de TIMP-2 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le tabagisme et l'obésité sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour TIMP-2 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut influencer négativement les niveaux de TIMP-2." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques pour TIMP-2 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines variations génétiques peuvent affecter l'expression de TIMP-2." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de TIMP-2 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut augmenter le risque de dysrégulation de TIMP-2." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter TIMP-2 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent perturber l'équilibre de TIMP-2 dans l'organisme." } } ] } ] }

Sources (10000 au total)

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.

Pancreatic ductal adenocarcinoma (PDAC) has limited therapeutic options, particularly with immune checkpoint inhibitors. Highly chemoresistant 'stem-like' cells, known as cancer stem cells (CSCs), are... We used the KPC mouse model (... Using the KPC mouse model, we functionally confirmed a population of cells marked by EpCAM, Sca-1 and CD133 as authentic CSCs and investigated their transcriptional profile. Immune evasion signatures/... This study establishes PGLYRP1 as a novel CSC-associated marker crucial for immune evasion, particularly against macrophage phagocytosis and T-cell killing, presenting it as a promising target for PDA...

A lightweight hybrid model for the automatic recognition of uterine fibroid ultrasound images based on deep learning.

Uterine fibroids (UF) are the most frequent tumors in ladies and can pose an enormous threat to complications, such as miscarriage. The accuracy of prognosis may also be affected by way of doctor inex... A hybrid model has been proposed that combines the MobileNetV2 community and deep convolutional generative adversarial networks (DCGAN) into useful resources for medical practitioners in figuring out ... The overall performance of the hybrid model contrasts with different models. The hybrid model achieves a real-time classification velocity of 40 frames per second (FPS), an accuracy of 97.45%, and an ... By using this deep learning hybrid approach, we address the shortcomings of the current classification methods of uterine fibroid....

Detection and Recognition of the Invasive species, Hylurgus ligniperda, in Traps, Based on a Cascaded Convolution Neural Network.

Hylurgus ligniperda, an invasive species originating from Eurasia, is now a major forestry quarantine pest worldwide. In recent years, it has caused significant damage in China. While traps have been ... Two cascade convolutional neural network models were employed in two stages to detect both target and non-target insects from images captured in the same forest. Initially, You Only Look Once X (YOLOX... Application of the cascade convolutional neural network model accurately identified H. ligniperda, and Mean F...

Major depressive disorder recognition by quantifying EEG signal complexity using proposed APLZC and AWPLZC.

Seeking objective quantitative indicators is important for accurately recognizing major depressive disorder (MDD). Lempel-Ziv complexity (LZC), employed to characterize neurological disorders, faces l... This work proposed Adaptive Permutation Lempel-Ziv Complexity (APLZC) and Adaptive Weighted Permutation Lempel-Ziv Complexity (AWPLZC) algorithms by refining the coarse-graining process and introducin... LZC, APLZC, and AWPLZC algorithms achieved accuracy rates of 78.29 %, 90.32 %, and 95.13 %, respectively. Sensitivities reached 67.96 %, 85.04 %, and 98.86 %, while specificities were 88.62 %, 95.35 %... The sample size is relatively small.... APLZC and AWPLZC algorithms, particularly AWPLZC, demonstrate superior effectiveness in differentiating MDD patients from HCs compared with LZC. These findings hold significant clinical implications f...

Novel evaluation method for facial nerve palsy using 3D facial recognition system in iPhone.

While subjective methods like the Yanagihara system and the House-Brackmann system are standard in evaluating facial paralysis, they are limited by intra- and inter-observer variability. Meanwhile, qu... We developed an application software (app) that utilizes the facial recognition functionality of the iPhone (Apple Inc., Cupertino, USA) for facial movement evaluation. This app leverages the phone's ... Our app provided an intuitive user experience, completing evaluations in under a minute, and thus proving practical for regular use. Its evaluation scores correlated highly with the Yanagihara system,... Our novel iPhone app offers a valuable tool for the comprehensive and efficient evaluation of facial palsy....